Compare MedManage Systems vs Transpharma
Customers evaluate the quality of MedManage Systems's products using the following success metrics.
Overview
MedManage Systems is 25 yrs old and is based in United States.
MedManage Systems, Inc. aims to provide drug sampling solutions. The company's OmniSampleSM Solution aims to allow pharmaceutical companies to intensify physician use of trial medications, thereby increasing product revenues.
Transpharma is 24 yrs old and is based in Israel.
TransPharma develops a transdermal drug delivery platform based on its RF-MicroChannel technology. This patented technology is employed in its clinically proven and commercially viable drug delivery system, ViaDerm. The ViaDerm system, designed for home use, aims to enable painless, needle-free, user-friendly delivery of drug compounds through the outer layer of the skin into the systemic circulation. a range of drug molecules from small to large molecules, such as peptides and proteins, may be administered using the ViaDerm system. The company's management team have experience in medical devices and pharmaceuticals development. In March 2012, Transpharma was acquired by Syneron Medical. The valuation of Transpharma was $3.6 million.
Demo Video
Leadership
Cecil Kost (Chief Executive Officer)
Yossi Gross (Founder)
Investors
Prism VentureWorks, Lilly Ventures
Candela, Evergreen Venture Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because MedManage Systems has not claimed their profile.
Work for MedManage Systems? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for MedManage Systems?
Claim your profile now.
Information not available because Transpharma has not claimed their profile.
Work for Transpharma? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Transpharma?
Claim your profile now.